ETIHX vs. FBTTX
Compare and contrast key facts about Eventide Healthcare & Life Sciences Fund (ETIHX) and Fidelity Advisor Biotechnology Fund Class M (FBTTX).
ETIHX is managed by Eventide Funds. It was launched on Dec 26, 2012. FBTTX is managed by Fidelity. It was launched on Dec 27, 2000.
Performance
ETIHX vs. FBTTX - Performance Comparison
Loading graphics...
ETIHX vs. FBTTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ETIHX Eventide Healthcare & Life Sciences Fund | -4.72% | 56.73% | -10.13% | 11.01% | -19.62% | -16.87% | 37.12% | 58.74% | -0.27% | 45.83% |
FBTTX Fidelity Advisor Biotechnology Fund Class M | 2.18% | 39.21% | 5.08% | 10.43% | -8.22% | -3.35% | 31.82% | 25.39% | -4.19% | 25.37% |
Returns By Period
In the year-to-date period, ETIHX achieves a -4.72% return, which is significantly lower than FBTTX's 2.18% return. Over the past 10 years, ETIHX has outperformed FBTTX with an annualized return of 12.95%, while FBTTX has yielded a comparatively lower 11.54% annualized return.
ETIHX
- 1D
- 6.18%
- 1M
- -2.47%
- YTD
- -4.72%
- 6M
- 20.62%
- 1Y
- 66.40%
- 3Y*
- 14.82%
- 5Y*
- 1.31%
- 10Y*
- 12.95%
FBTTX
- 1D
- 5.09%
- 1M
- -0.77%
- YTD
- 2.18%
- 6M
- 15.39%
- 1Y
- 55.03%
- 3Y*
- 20.14%
- 5Y*
- 8.63%
- 10Y*
- 11.54%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
ETIHX vs. FBTTX - Expense Ratio Comparison
ETIHX has a 1.30% expense ratio, which is higher than FBTTX's 1.28% expense ratio.
Return for Risk
ETIHX vs. FBTTX — Risk / Return Rank
ETIHX
FBTTX
ETIHX vs. FBTTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Eventide Healthcare & Life Sciences Fund (ETIHX) and Fidelity Advisor Biotechnology Fund Class M (FBTTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ETIHX | FBTTX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 2.33 | 1.92 | +0.40 |
Sortino ratioReturn per unit of downside risk | 3.06 | 2.52 | +0.54 |
Omega ratioGain probability vs. loss probability | 1.39 | 1.32 | +0.06 |
Calmar ratioReturn relative to maximum drawdown | 4.26 | 3.13 | +1.13 |
Martin ratioReturn relative to average drawdown | 14.67 | 12.48 | +2.19 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| ETIHX | FBTTX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.33 | 1.92 | +0.40 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.05 | 0.37 | -0.33 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.46 | 0.47 | -0.01 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.52 | 0.30 | +0.22 |
Correlation
The correlation between ETIHX and FBTTX is 0.89, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
ETIHX vs. FBTTX - Dividend Comparison
ETIHX has not paid dividends to shareholders, while FBTTX's dividend yield for the trailing twelve months is around 1.50%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ETIHX Eventide Healthcare & Life Sciences Fund | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 10.78% | 3.49% | 2.08% | 7.33% | 1.28% | 0.00% | 1.22% |
FBTTX Fidelity Advisor Biotechnology Fund Class M | 1.50% | 1.53% | 6.41% | 0.93% | 0.00% | 21.60% | 8.79% | 7.10% | 2.64% | 0.00% | 0.00% | 5.42% |
Drawdowns
ETIHX vs. FBTTX - Drawdown Comparison
The maximum ETIHX drawdown since its inception was -55.11%, smaller than the maximum FBTTX drawdown of -63.75%. Use the drawdown chart below to compare losses from any high point for ETIHX and FBTTX.
Loading graphics...
Drawdown Indicators
| ETIHX | FBTTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -55.11% | -63.75% | +8.64% |
Max Drawdown (1Y)Largest decline over 1 year | -12.50% | -13.58% | +1.08% |
Max Drawdown (5Y)Largest decline over 5 years | -49.49% | -36.64% | -12.85% |
Max Drawdown (10Y)Largest decline over 10 years | -55.11% | -39.04% | -16.07% |
Current DrawdownCurrent decline from peak | -7.09% | -2.61% | -4.48% |
Average DrawdownAverage peak-to-trough decline | -18.17% | -21.95% | +3.78% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.79% | 3.72% | +0.07% |
Volatility
ETIHX vs. FBTTX - Volatility Comparison
Eventide Healthcare & Life Sciences Fund (ETIHX) has a higher volatility of 10.04% compared to Fidelity Advisor Biotechnology Fund Class M (FBTTX) at 9.37%. This indicates that ETIHX's price experiences larger fluctuations and is considered to be riskier than FBTTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| ETIHX | FBTTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.04% | 9.37% | +0.67% |
Volatility (6M)Calculated over the trailing 6-month period | 17.34% | 17.02% | +0.32% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.36% | 25.99% | +0.37% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 27.84% | 23.31% | +4.53% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 28.46% | 24.58% | +3.88% |